Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Alpha-Mannosidosis Participant: An International, Multicenter, Epidemiological Protocol

NCT03651245 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.

NCT NCT03651245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03651245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Alpha-Mannosidosis Participant: An International, Multicenter, Epidemiological Protocol
Lead sponsor
CENTOGENE GmbH Rostock
Phase
Observational
Overall status
Terminated
Start date
August 20, 2018
Completion date
May 30, 2022
Enrollment
667 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

deafness, facial dysmorphism, gingival hypertrophy, immunodeficiency, mental retardation, skeletal abnormalities